A Potential Nasal Spray for COVID-19 in the Works, with Dr. Hector Aguilar-Carreno

Send us Fan MailIn this episode of Causes or Cures, Dr. Eeks chats with Dr. Hector Aguilar-Carreno about his and his team's research published in Nature, May'22 titled:  A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. In the podcast, he will break down the study and in an easy-to-understand way explain what TMPRSS2 is and how it relates to COVID-19 infection; the inhibitors and how they work; results when tested on cells and mice; why a nasal spray would be the most ideal way to administer this; public health implications, and where they are at in the research process.  Dr. Aguilar-Carreno is a virologist, professor and researcher with the Department of Microbiology and Immunology at Cornell University College of Veterinary Medicine. You can contact Dr. Eeks at bloomingwellness.com.Follow Dr. Eeks on Instagram here.Or Facebook here.Or Twitter.Subscribe to her newsletter here!Support the show